96 related articles for article (PubMed ID: 2892361)
1. Glycoconjugate receptors for bacteria attaching to mucosal sites: examples for Escherichia coli and Streptococcus pneumoniae.
Svanborg Eden C; Andersson B; Aniansson G; Leffler H; Lomberg H; Mestecky J; Wold AE
Adv Exp Med Biol; 1987; 216B():931-9. PubMed ID: 2892361
[No Abstract] [Full Text] [Related]
2. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of enteropathogenic Escherichia coli (strain RDEC-1) adherence to rabbit intestinal brush borders by milk immune secretory immunoglobulin A.
Boedeker EC; Cheney CP; Cantey JR
Adv Exp Med Biol; 1987; 216B():919-30. PubMed ID: 3321942
[No Abstract] [Full Text] [Related]
4. Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides.
Finn A; Zhang Q; Seymour L; Fasching C; Pettitt E; Janoff EN
J Infect Dis; 2002 Nov; 186(10):1422-9. PubMed ID: 12404157
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of enteropathogenic Escherichia coli (EPEC) adherence to HeLa cells by human colostrum. Detection of specific sIgA related to EPEC outer-membrane proteins.
Câmara LM; Carbonare SB; Scaletsky IC; da Silva ML; Carneiro-Sampaio MM
Adv Exp Med Biol; 1995; 371A():673-6. PubMed ID: 8526016
[No Abstract] [Full Text] [Related]
6. Bladder defense mechanisms against urinary tract infections.
Schaeffer AJ
Semin Urol; 1983 May; 1(2):106-13. PubMed ID: 6382529
[No Abstract] [Full Text] [Related]
7. Protective factors in milk and the development of the immune system.
Hanson LA; Ahlstedt S; Andersson B; Carlsson B; Fällström SP; Mellander L; Porras O; Söderström T; Edén CS
Pediatrics; 1985 Jan; 75(1 Pt 2):172-6. PubMed ID: 3880886
[TBL] [Abstract][Full Text] [Related]
8. Agglutination of E. coli by secretory IgA--a result of interaction between bacterial mannose-specific adhesins and immunoglobulin carbohydrate?
Wold AE; Mestecky J; Svanborg Edén C
Monogr Allergy; 1988; 24():307-9. PubMed ID: 2896295
[No Abstract] [Full Text] [Related]
9. Human milk: Defense against infection.
Hanson LA; Söderström T
Prog Clin Biol Res; 1981; 61():147-59. PubMed ID: 6798576
[TBL] [Abstract][Full Text] [Related]
10. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain.
Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC
Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258
[TBL] [Abstract][Full Text] [Related]
11. New attempts and possibilities in prevention and treatment of intestinal coli-infections in infants.
Lodinová R; Jouja V; Vinsová N; Vocel J; Melková J
Czech Med; 1980; 3(1):47-58. PubMed ID: 6987048
[No Abstract] [Full Text] [Related]
12. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
[TBL] [Abstract][Full Text] [Related]
13. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
Langermann S; Ballou WR
J Infect Dis; 2001 Mar; 183 Suppl 1():S84-6. PubMed ID: 11171023
[No Abstract] [Full Text] [Related]
14. [Ways of bacterial attachment to mucous surfaces and possibilities of preventing the infections].
Timoşca S; Liscă M
Rev Med Chir Soc Med Nat Iasi; 1982; 86(2):237-42. PubMed ID: 25588242
[No Abstract] [Full Text] [Related]
15. [Prospects for the production of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (1)].
Cravioto A
Bol Med Hosp Infant Mex; 1984 Mar; 41(3):122-8. PubMed ID: 6144315
[No Abstract] [Full Text] [Related]
16. [Presence of specific factors in mother's milk against strains of diarrhea-causing Escherichia coli in humans].
Cravioto A
Gac Med Mex; 1990; 126(1):35-42; discussion 42-3. PubMed ID: 2194884
[TBL] [Abstract][Full Text] [Related]
17. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
Lin H; Peng Y; Lin Z; Zhang S; Guo Y
Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
[TBL] [Abstract][Full Text] [Related]
18. Nonfimbrial adhesins of Escherichia coli.
Goldhar J
Adv Exp Med Biol; 1996; 408():63-72. PubMed ID: 8895778
[No Abstract] [Full Text] [Related]
19. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
Simell B; Korkeila M; Pursiainen H; Kilpi TM; Käyhty H
J Infect Dis; 2001 Mar; 183(6):887-96. PubMed ID: 11237805
[TBL] [Abstract][Full Text] [Related]
20. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
Nigrovic LE; Kuppermann N; Malley R;
Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
